Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 1, 2007

Althea and Blueshift Combine Technologies for Gene Expression Screening

  • Althea Technologies and Blueshift Biotechnologies report that Althea received a SBIR award from the NHGRI to explore the potential for practical high-throughput and low-cost gene expression analysis.

    The grant proposes the development of gene expression profiling methods that make use of Althea's technology in multiplexed PCR (XP™-PCR)* methods and Blueshift's IsoCyte™ platform. This platform is a high-throughput laser scanner adapted from semiconductor inspection technology that provides multicolor fluorescence, anisotropy, and scatter images for high-content and object-based multiplexed array formats.

    The combined technologies may enable implementation of quantitative gene expression profiling in an automated high-throughput platform, providing highly specific and quantitative results for as many as 768 samples per minute.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »